600
Participants
Start Date
September 22, 2025
Primary Completion Date
October 1, 2027
Study Completion Date
January 15, 2028
IVM-Fresh (No gonadotropin + Fresh embryo transfer)
Patients randomized to this arm will receive estradiol valerate 8 mg/day. IVM will be performed after ≥10 days of estrogen and ET ≥8 mm. From the day of ICSI, they will continue estradiol and start vaginal progesterone 800 mg/day + dydrogesterone (20mg/day). A fresh embryo transfer will subsequently be performed.
IVF-FET (GnRH-Antagonist - Agonist Trigger - Frozen embryo transfer)
Patients randomized into this group will receive FSH at a dose of 150 IU/day. Oocyte retrieval will be performed once the criteria for triggering are fulfilled, followed by embryo cryopreservation and frozen embryo transfer in the subsequent cycle. Endometrial preparation for frozen embryo transfer will be conducted using an exogenous steroids regimen. Patients will receive estradiol 8 mg/day starting from cycle days 2-3 for 10 days. When the endometrial thickness reaches ≥8 mm, luteal phase support will be initiated with vaginal progesterone 800 mg/day plus dydrogesterone 20 mg/day.
RECRUITING
IVFMD - My Duc Hospital, Ho Chi Minh City
Mỹ Đức Hospital
OTHER